DEPDC1 anticorps
Aperçu rapide pour DEPDC1 anticorps (ABIN7073717)
Antigène
Voir toutes DEPDC1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Réactivité croisée
- Souris, Rat
-
Purification
- Affinity purification
-
Immunogène
- KLH conjugated Synthetic peptide corresponding to Human DEPDC1
-
-
-
-
Indications d'application
- IHC/IF (M,R) 1:500-1:1500/1:500-1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS, pH 7.4, 0.02 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
-
- DEPDC1 (DEP Domain Containing 1 (DEPDC1))
-
Autre désignation
- DEPDC1
-
Sujet
- DEPDC1 is a 784 amino acid nuclear protein expressed in testis and up-regulated in bladder cancer cells. Containing a DEP domain and a Rho-GAP domain, DEPDC1 may play an essential role in the growth of bladder cancer cells, and is considered a novel protein target for bladder cancer therapy. Existing as five isoforms produced by alternative splicing events, DEPDC1 is encoded by a gene located on human chromosome 1, which spans 260 million base pairs, contains over 3,000 genes and comprises nearly 8 % of the human genome.
-
ID gène
- 76131
-
NCBI Accession
- NP_001165563
-
UniProt
- Q8CIG0
Antigène
-